Tenderwize
Back to tender search

Open-house rebate agreement for Tiaprid

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Dec 03, 2027 · 473 days left·Open·Supplies·Framework
Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Tiaprid, ATC N05AL03

62/100

Opportunity Score

Needs reviewMedium complexity
SuppliesFrameworkOpen
Why this score?

Opportunity

62 / 100

Complexity

58 / 100

Risk factors

The notice explicitly says the contract documents must be submitted via the communication area in the DTVP portal and n...

Only pharmaceutical companies are eligible as potential contract partners, and a signed declaration of reliability is r...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Jan 2028
  • Non-exclusive open-house rebate agreements for the medicinal product Tiaprid, ATC N05AL03.
  • Supply contract for pharmaceutical products.
Show full summary

This is an open-house pharmaceutical supply arrangement for Tiaprid (ATC N05AL03) led by AOK Bayern. It is not a competitive open procedure in substance: the notice states that all interested pharmaceutical companies meeting the stated suitability requirement may join on identical, non-negotiable terms. The contract period runs from 2026-02-01 to 2028-01-31, with contract entry possible until 2027-12-03. Submission is via DTVP electronic channel with a qualified electronic signature, or by signed paper originals in duplicate. No contract value is stated.

Risks

The notice explicitly says the contract documents must be submitted via the communication area in the DTVP portal and n...

Only pharmaceutical companies are eligible as potential contract partners, and a signed declaration of reliability is r...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Eligibility

  • Only pharmaceutical companies are eligible as potential contract partners.

Administrative

  • Submit the signed contract, the completed annex 'Festlegung der vertragsgegenständlichen Arzneimittel', and the signed declaration of reliability.
  • The declaration of reliability must be signed and submitted with the tender documents.

Buyer

Location

München, DEU

Website

www.aok.de

Buyer profile

Open profile

Identifier

DE811695320

Activity

Health

Lots (1)

LOT-0001

Open-house rebate agreement for Tiaprid

Open-house non-exclusive pharmaceutical rebate agreement for Tiaprid (ATC N05AL03). Scope is supply of pharmaceutical products under a pre-set contract; the notice says the contract terms are identical and not individually negotiable. Place of performance is Germany, region DE212 (Bavaria/Munich area as indicated by buyer address and lot data).

SuppliesFrameworkEU fundedElectronic submission

Location

DE212, Germany

Duration

Jan 2026 - Jan 2028

Category

Pharmaceutical products

Deadline

Deadline Dec 03, 2027

Procurement Details

Publication date
14 Dec 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
831717-2025

Documents (2)

Similar tenders